Published: May 27, 2021, 22:20 IST | Updated: May 27, 2021, 22:20 IST
The government defended India's vaccine procurement policy by issuing a separate document denying the recent criticism. It cleared that the India is in talks with Pfizer and is considering seeking compensation for any adverse effects when its vaccine is implemented in India.